Kyle Lapham

Kyle Lapham is the Chief Technology Officer (CTO) at PACT Pharma, a biotechnology company focused on developing personalized cancer immunotherapies. In his role, he is responsible for overseeing the technological strategies and advancements that drive the company's mission to create effective treatments tailored to individual patients.

Lapham has a strong background in technology and engineering, with experience in various leadership roles within the biotech and pharmaceutical industries. His expertise includes areas such as drug development, process engineering, and the application of innovative technologies in healthcare.

His educational background and previous positions have equipped him with a deep understanding of both the scientific and operational aspects of biotechnology, allowing him to effectively lead PACT Pharma's technological initiatives.